An outcomes model for type 2 diabetes View Homepage


Ontology type: schema:MonetaryGrant     


Grant Info

YEARS

2009-2013

FUNDING AMOUNT

465563.0 GBP

ABSTRACT

Type 2 diabetes is an increasingly common chronic disease which can cause a wide range of serious complications including heart disease and blindness. We propose improving and making widely accessible a model which simulates the likely course of the disease for patients, given their particular characteristics such as blood pressure, current age and time since diagnosis. The model is based on information from patients in the United Kingdom Prospective Diabetes Study, a landmark study of diabetes treatment. It has already been found to give more accurate predictions than other diabetes models, and is being used by researchers in many countries. Some elements now need to be updated, and it needs to be made more user-friendly. Our model will then give patients and their doctors valuable information on current prognosis and the benefits of therapy. The usefulness of the model to other researchers will also be greatly enhanced. Technical Summary The prevalence of Type 2 diabetes is increasing, and it is associated with a wide range of serious complications including heart disease and blindness. Because of its potentially long duration, simulation models are particularly valuable in understanding and estimating the lifetime risk of complications and the effects of modifying risk factors. The United Kingdom Prospective Diabetes Study Outcomes Model is a well-established and validated model based on patient-level data from this landmark study of diabetes treatment. It has already been found to compare favourably with other diabetes models in predictive comparions, and is being used by academic researchers, reimbursement and other public agencies and industry in many countries. This research proposal has three elements: first to implement a set of model improvements and updates, in particular focusing on changes in fatality rates following diabetes-related complications and changes in death from other causes; second, to undertake a wide-ranging set of external validations, comparing model predictions of event rates given baseline characteristics and risk factor changes against observed event rates in a large number of recent trials; and third to significantly improve the usability and accessibility of the model, both for the research community and so that patients and their doctors can readily use it to obtain valuable information on current prognosis and the benefits of therapy. More... »

URL

https://gtr.ukri.org/project/AE409F2D-9A84-410B-9516-6BB9ABBE5964

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "amount": {
      "currency": "GBP", 
      "type": "MonetaryAmount", 
      "value": 465563.0
    }, 
    "description": "Type 2 diabetes is an increasingly common chronic disease which can cause a wide range of serious complications including heart disease and blindness. We propose improving and making widely accessible a model which simulates the likely course of the disease for patients, given their particular characteristics such as blood pressure, current age and time since diagnosis. The model is based on information from patients in the United Kingdom Prospective Diabetes Study, a landmark study of diabetes treatment. It has already been found to give more accurate predictions than other diabetes models, and is being used by researchers in many countries. Some elements now need to be updated, and it needs to be made more user-friendly. Our model will then give patients and their doctors valuable information on current prognosis and the benefits of therapy. The usefulness of the model to other researchers will also be greatly enhanced.\n\nTechnical Summary\nThe prevalence of Type 2 diabetes is increasing, and it is associated with a wide range of serious complications including heart disease and blindness. Because of its potentially long duration, simulation models are particularly valuable in understanding and estimating the lifetime risk of complications and the effects of modifying risk factors. The United Kingdom Prospective Diabetes Study Outcomes Model is a well-established and validated model based on patient-level data from this landmark study of diabetes treatment. It has already been found to compare favourably with other diabetes models in predictive comparions, and is being used by academic researchers, reimbursement and other public agencies and industry in many countries. This research proposal has three elements: first to implement a set of model improvements and updates, in particular focusing on changes in fatality rates following diabetes-related complications and changes in death from other causes; second, to undertake a wide-ranging set of external validations, comparing model predictions of event rates given baseline characteristics and risk factor changes against observed event rates in a large number of recent trials; and third to significantly improve the usability and accessibility of the model, both for the research community and so that patients and their doctors can readily use it to obtain valuable information on current prognosis and the benefits of therapy.", 
    "endDate": "2013-06-06", 
    "funder": {
      "id": "http://www.grid.ac/institutes/grid.14105.31", 
      "type": "Organization"
    }, 
    "id": "sg:grant.2773877", 
    "identifier": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "grant.2773877"
        ]
      }, 
      {
        "name": "gtr_id", 
        "type": "PropertyValue", 
        "value": [
          "AE409F2D-9A84-410B-9516-6BB9ABBE5964"
        ]
      }
    ], 
    "inLanguage": [
      "en"
    ], 
    "keywords": [
      "type 2 diabetes", 
      "benefits of therapy", 
      "serious complications", 
      "heart disease", 
      "diabetes model", 
      "diabetes treatment", 
      "United Kingdom Prospective Diabetes Study", 
      "current prognosis", 
      "United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model", 
      "event rates", 
      "diabetes-related complications", 
      "risk factor changes", 
      "common chronic diseases", 
      "patient-level data", 
      "landmark studies", 
      "baseline characteristics", 
      "blood pressure", 
      "Diabetes Study", 
      "recent trials", 
      "lifetime risk", 
      "risk factors", 
      "chronic diseases", 
      "fatality rate", 
      "complications", 
      "outcome model", 
      "patients", 
      "diabetes", 
      "disease", 
      "longer duration", 
      "observed event rates", 
      "prognosis", 
      "external validation", 
      "therapy", 
      "current age", 
      "blindness", 
      "treatment", 
      "likely course", 
      "prevalence", 
      "factor changes", 
      "diagnosis", 
      "trials", 
      "study", 
      "death", 
      "age", 
      "rate", 
      "risk", 
      "reimbursement", 
      "doctors", 
      "valuable information", 
      "cause", 
      "duration", 
      "changes", 
      "benefits", 
      "course", 
      "factors", 
      "summary", 
      "update", 
      "countries", 
      "usefulness", 
      "effect", 
      "improvement", 
      "large number", 
      "pressure", 
      "information", 
      "characteristics", 
      "wide range", 
      "data", 
      "model", 
      "research proposals", 
      "number", 
      "comparion", 
      "time", 
      "particular characteristics", 
      "validation", 
      "understanding", 
      "researchers", 
      "accessibility", 
      "range", 
      "community", 
      "agencies", 
      "academic researchers", 
      "more accurate predictions", 
      "prediction", 
      "accurate prediction", 
      "usability", 
      "elements", 
      "research community", 
      "set", 
      "technical summary", 
      "proposal", 
      "public agencies", 
      "industry", 
      "model predictions", 
      "simulation model", 
      "model improvement"
    ], 
    "name": "An outcomes model for type 2 diabetes", 
    "recipient": [
      {
        "id": "http://www.grid.ac/institutes/grid.4991.5", 
        "type": "Organization"
      }, 
      {
        "id": "http://www.grid.ac/institutes/grid.10825.3e", 
        "type": "Organization"
      }, 
      {
        "id": "http://www.grid.ac/institutes/grid.7605.4", 
        "type": "Organization"
      }, 
      {
        "id": "http://www.grid.ac/institutes/grid.1008.9", 
        "type": "Organization"
      }, 
      {
        "affiliation": {
          "id": "http://www.grid.ac/institutes/None", 
          "name": "University of Oxford", 
          "type": "Organization"
        }, 
        "familyName": "Gray", 
        "givenName": "Alastair", 
        "id": "sg:person.01307325071.02", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.01307325071.02", 
        "roleName": "PI", 
        "type": "Role"
      }, 
      {
        "affiliation": {
          "id": "http://www.grid.ac/institutes/None", 
          "name": "University of Melbourne", 
          "type": "Organization"
        }, 
        "familyName": "Clarke", 
        "givenName": "Philip", 
        "id": "sg:person.0734456474.38", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.0734456474.38", 
        "roleName": "Co-PI", 
        "type": "Role"
      }, 
      {
        "affiliation": {
          "id": "http://www.grid.ac/institutes/None", 
          "name": "University of Oxford", 
          "type": "Organization"
        }, 
        "familyName": "Goldacre", 
        "givenName": "Michael", 
        "id": "sg:person.01330462633.80", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.01330462633.80", 
        "roleName": "Co-PI", 
        "type": "Role"
      }, 
      {
        "affiliation": {
          "id": "http://www.grid.ac/institutes/None", 
          "name": "University of Oxford", 
          "type": "Organization"
        }, 
        "familyName": "Holman", 
        "givenName": "Rury", 
        "id": "sg:person.01017043005.08", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.01017043005.08", 
        "roleName": "Co-PI", 
        "type": "Role"
      }, 
      {
        "affiliation": {
          "id": "http://www.grid.ac/institutes/None", 
          "name": "University of Oxford", 
          "type": "Organization"
        }, 
        "familyName": "Mihaylova", 
        "givenName": "Borislava", 
        "id": "sg:person.0775757667.19", 
        "type": "Person"
      }, 
      {
        "member": "sg:person.0775757667.19", 
        "roleName": "Co-PI", 
        "type": "Role"
      }
    ], 
    "sameAs": [
      "https://app.dimensions.ai/details/grant/grant.2773877"
    ], 
    "sdDataset": "grants", 
    "sdDatePublished": "2021-11-01T19:05", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211101/entities/gbq_results/grant/grant_35.jsonl", 
    "startDate": "2009-08-31", 
    "type": "MonetaryGrant", 
    "url": "https://gtr.ukri.org/project/AE409F2D-9A84-410B-9516-6BB9ABBE5964"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/grant.2773877'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/grant.2773877'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/grant.2773877'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/grant.2773877'


 

This table displays all metadata directly associated to this object as RDF triples.

183 TRIPLES      19 PREDICATES      128 URIs      113 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:grant.2773877 schema:about anzsrc-for:11
2 schema:amount N9e1cac32e91741ecb94bf51ea44b5ed4
3 schema:description Type 2 diabetes is an increasingly common chronic disease which can cause a wide range of serious complications including heart disease and blindness. We propose improving and making widely accessible a model which simulates the likely course of the disease for patients, given their particular characteristics such as blood pressure, current age and time since diagnosis. The model is based on information from patients in the United Kingdom Prospective Diabetes Study, a landmark study of diabetes treatment. It has already been found to give more accurate predictions than other diabetes models, and is being used by researchers in many countries. Some elements now need to be updated, and it needs to be made more user-friendly. Our model will then give patients and their doctors valuable information on current prognosis and the benefits of therapy. The usefulness of the model to other researchers will also be greatly enhanced. Technical Summary The prevalence of Type 2 diabetes is increasing, and it is associated with a wide range of serious complications including heart disease and blindness. Because of its potentially long duration, simulation models are particularly valuable in understanding and estimating the lifetime risk of complications and the effects of modifying risk factors. The United Kingdom Prospective Diabetes Study Outcomes Model is a well-established and validated model based on patient-level data from this landmark study of diabetes treatment. It has already been found to compare favourably with other diabetes models in predictive comparions, and is being used by academic researchers, reimbursement and other public agencies and industry in many countries. This research proposal has three elements: first to implement a set of model improvements and updates, in particular focusing on changes in fatality rates following diabetes-related complications and changes in death from other causes; second, to undertake a wide-ranging set of external validations, comparing model predictions of event rates given baseline characteristics and risk factor changes against observed event rates in a large number of recent trials; and third to significantly improve the usability and accessibility of the model, both for the research community and so that patients and their doctors can readily use it to obtain valuable information on current prognosis and the benefits of therapy.
4 schema:endDate 2013-06-06
5 schema:funder grid-institutes:grid.14105.31
6 schema:identifier N1ff09269c08749a6b48d7aac0253f6c8
7 N578f75ecbc9747b3b884eaf3f6c853ca
8 schema:inLanguage en
9 schema:keywords Diabetes Study
10 United Kingdom Prospective Diabetes Study
11 United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model
12 academic researchers
13 accessibility
14 accurate prediction
15 age
16 agencies
17 baseline characteristics
18 benefits
19 benefits of therapy
20 blindness
21 blood pressure
22 cause
23 changes
24 characteristics
25 chronic diseases
26 common chronic diseases
27 community
28 comparion
29 complications
30 countries
31 course
32 current age
33 current prognosis
34 data
35 death
36 diabetes
37 diabetes model
38 diabetes treatment
39 diabetes-related complications
40 diagnosis
41 disease
42 doctors
43 duration
44 effect
45 elements
46 event rates
47 external validation
48 factor changes
49 factors
50 fatality rate
51 heart disease
52 improvement
53 industry
54 information
55 landmark studies
56 large number
57 lifetime risk
58 likely course
59 longer duration
60 model
61 model improvement
62 model predictions
63 more accurate predictions
64 number
65 observed event rates
66 outcome model
67 particular characteristics
68 patient-level data
69 patients
70 prediction
71 pressure
72 prevalence
73 prognosis
74 proposal
75 public agencies
76 range
77 rate
78 recent trials
79 reimbursement
80 research community
81 research proposals
82 researchers
83 risk
84 risk factor changes
85 risk factors
86 serious complications
87 set
88 simulation model
89 study
90 summary
91 technical summary
92 therapy
93 time
94 treatment
95 trials
96 type 2 diabetes
97 understanding
98 update
99 usability
100 usefulness
101 validation
102 valuable information
103 wide range
104 schema:name An outcomes model for type 2 diabetes
105 schema:recipient N1b444ecd4e7243849c20949dddca204a
106 N20781d130e994e7caeb5a7fe85d1e03a
107 N316c9cc679294fa298b741478a788b16
108 Na19d85dcd9b7426392293c6e7f594083
109 Nf1306755cc7740bc97faad05ee1ea62e
110 sg:person.01017043005.08
111 sg:person.01307325071.02
112 sg:person.01330462633.80
113 sg:person.0734456474.38
114 sg:person.0775757667.19
115 grid-institutes:grid.1008.9
116 grid-institutes:grid.10825.3e
117 grid-institutes:grid.4991.5
118 grid-institutes:grid.7605.4
119 schema:sameAs https://app.dimensions.ai/details/grant/grant.2773877
120 schema:sdDatePublished 2021-11-01T19:05
121 schema:sdLicense https://scigraph.springernature.com/explorer/license/
122 schema:sdPublisher N163efd57bae943e2a91ef397e11d886a
123 schema:startDate 2009-08-31
124 schema:url https://gtr.ukri.org/project/AE409F2D-9A84-410B-9516-6BB9ABBE5964
125 sgo:license sg:explorer/license/
126 sgo:sdDataset grants
127 rdf:type schema:MonetaryGrant
128 N163efd57bae943e2a91ef397e11d886a schema:name Springer Nature - SN SciGraph project
129 rdf:type schema:Organization
130 N1b444ecd4e7243849c20949dddca204a schema:member sg:person.0734456474.38
131 schema:roleName Co-PI
132 rdf:type schema:Role
133 N1ff09269c08749a6b48d7aac0253f6c8 schema:name dimensions_id
134 schema:value grant.2773877
135 rdf:type schema:PropertyValue
136 N20781d130e994e7caeb5a7fe85d1e03a schema:member sg:person.01330462633.80
137 schema:roleName Co-PI
138 rdf:type schema:Role
139 N316c9cc679294fa298b741478a788b16 schema:member sg:person.01307325071.02
140 schema:roleName PI
141 rdf:type schema:Role
142 N578f75ecbc9747b3b884eaf3f6c853ca schema:name gtr_id
143 schema:value AE409F2D-9A84-410B-9516-6BB9ABBE5964
144 rdf:type schema:PropertyValue
145 N9e1cac32e91741ecb94bf51ea44b5ed4 schema:currency GBP
146 schema:value 465563.0
147 rdf:type schema:MonetaryAmount
148 Na19d85dcd9b7426392293c6e7f594083 schema:member sg:person.01017043005.08
149 schema:roleName Co-PI
150 rdf:type schema:Role
151 Nf1306755cc7740bc97faad05ee1ea62e schema:member sg:person.0775757667.19
152 schema:roleName Co-PI
153 rdf:type schema:Role
154 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
155 rdf:type schema:DefinedTerm
156 sg:person.01017043005.08 schema:affiliation grid-institutes:None
157 schema:familyName Holman
158 schema:givenName Rury
159 rdf:type schema:Person
160 sg:person.01307325071.02 schema:affiliation grid-institutes:None
161 schema:familyName Gray
162 schema:givenName Alastair
163 rdf:type schema:Person
164 sg:person.01330462633.80 schema:affiliation grid-institutes:None
165 schema:familyName Goldacre
166 schema:givenName Michael
167 rdf:type schema:Person
168 sg:person.0734456474.38 schema:affiliation grid-institutes:None
169 schema:familyName Clarke
170 schema:givenName Philip
171 rdf:type schema:Person
172 sg:person.0775757667.19 schema:affiliation grid-institutes:None
173 schema:familyName Mihaylova
174 schema:givenName Borislava
175 rdf:type schema:Person
176 grid-institutes:None schema:name University of Melbourne
177 University of Oxford
178 rdf:type schema:Organization
179 grid-institutes:grid.1008.9 schema:Organization
180 grid-institutes:grid.10825.3e schema:Organization
181 grid-institutes:grid.14105.31 schema:Organization
182 grid-institutes:grid.4991.5 schema:Organization
183 grid-institutes:grid.7605.4 schema:Organization
 




Preview window. Press ESC to close (or click here)


...